Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects

J Am Soc Nephrol. 2024 Jan 1;35(1):129. doi: 10.1681/ASN.0000000000000246.

Authors

Yanqin Li¹, Fan Luo, Qi Gao, Licong Su

Affiliation

¹ Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.

PMID: 38170602
PMCID: PMC10881180 (available on 2025-01-01)
DOI: 10.1681/ASN.0000000000000246

No abstract available

MeSH terms

Humans
Immunosuppressive Agents* / adverse effects
Kidney Transplantation*
Lipids

Substances

Immunosuppressive Agents
Lipids

Grants and funding